How to Buy Kazia Therapeutics Stock
Kazia Therapeutics Ltd
Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma.
Kazia Therapeutics stock last closed at $13.39, down 1.83% from the previous day, and has increased 240.71% in one year. It has overperformed other stocks in the Biotechnology industry by 2.52 percentage points. Kazia Therapeutics stock is currently +339.02% from its 52-week low of $3.05, and -23.05% from its 52-week high of $17.40.
There are currently 5.67B shares of KZIA outstanding. The market cap of KZIA is $758.94M. In the last 24 hours, 229,000 KZIA shares were traded.
How to Buy Kazia Therapeutics Stock
Not sure how to invest in Kazia Therapeutics stock? Here's how.
- Choose where to buy Kazia Therapeutics stock: You need to pick an online brokerage, but don't worry - we've tested dozens of stock brokerages and apps to help you decide where to buy Kazia Therapeutics stock.
- Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Deposit money your brokerage account: Pick your payment method and add your info.
- Research Kazia Therapeutics stock: The Kazia Therapeutics ticker symbol is KZIA. Is Kazia Therapeutics stock a good investment? Should you buy shares of KZIA? How do KZIA's underlying business fundamentals look? Do top analysts think Kazia Therapeutics is a good buy? Why has KZIA's stock price moved recently? (Hint: Our stock research website can help you understand if KZIA is a good stock to buy).
- Make your KZIA trade: Decide if you will purchase KZIA shares at the current market price or use a limit order to buy KZIA stock at a specific price.
- Keep an eye on your investment in KZIA: Create a watchlist to key updates about your investment in Kazia Therapeutics shares.
Step 1: Choose where to buy Kazia Therapeutics stock
You will need an online brokerage account in order to access the NASDAQ market and buy KZIA stock.
Our preferred brokerage: eToro
We believe that eToro is the best brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to world markets: From Tech to Real Estate, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro offers a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've picked the right brokerage, you'll need to fill out some personal details so you are able to invest in KZIA today.
How to Open a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal info to start a new trading account.
- Submit your application by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit money your brokerage account
Now that you have created your account on app for investing, you can securely and quickly fund your account:
Watch this video walkthrough for more details transferring money into your new brokerage account.
Step 4: Research Kazia Therapeutics stock
After you have identified the best place to buy Kazia Therapeutics stock, it's critical to analyze their stock before you invest, so you actually understand the risk as well as the opportunity.
Kazia Therapeutics stock data
Fundamentals of Kazia Therapeutics
WallStreetZen was built to help everyday investors perform more accurate fundamental analysis.
You can see all of the due diligence checks on KZIA's stock page.
Is KZIA stock undervalued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge KZIA's intrinsic value.
Using relative valuations methods:
- KZIA may be overvalued based on its P/B ratio of 23.03x, relative to Biotechnology industry P/B ratio of 4.9x
You can do more valuation research on KZIA's stock here.
KZIA Financial Overview
Signs that KZIA is financially healthy:
- KZIA has cash burn of 10211616. It has sufficient cash and short-term investments to cover this for at least one year.
- KZIA has $49.26M in cash and short term investments. This is sufficient to cover its annual cash burn of $10.21M.
- There are more short-term assets than long-term liabilities on the KZIA balance sheet.
- There are more short-term assets than short-term liabilities on the KZIA balance sheet.
Signs that KZIA is not financially healthy:
- Total KZIA debt is higher than 5 years ago, relative to shareholder equity.
- KZIA has a relatively high debt to equity ratio of 0.53.
- KZIA profit margin has gone down from -1,134.8% to -1,200.9% in the past year.
Is it a good time to buy KZIA stock, according to analysts?
Out of 2 Wall Street analysts who give ratings on KZIA, the consensus analyst rating on Kazia Therapeutics is a Strong Buy
Please note that analyst ratings are not stock recommendations, nor are they financial advice.
You can dig deeper into what analysts are projecting on the Kazia Therapeutics stock forecast page.
KZIA Momentum
Is KZIA Growing Revenue?
Last year, KZIA revenue was $1.35M. Over the past five year, KZIA's revenue has increased by 30.77% per year. This was faster than the Biotechnology industry average of 26.84%.
Learn more about KZIA's earnings and revenue performance here.
Who is buying/selling KZIA?
In the last year, insiders at KZIA have not bought or sold any shares.
Dig into more about who owns KZIA shares here.
Can I rely on KZIA as an income stream?
No, Kazia Therapeutics doesn't provide an income stream by paying out dividends.
What do other investors have to say about KZIA?
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Make your KZIA trade
You have two main types of orders:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are mostly the best for newer investors. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to make sure you're buying or selling at a given price limit, place a limit order.
Press the Open Trade button and eToro will place the order.
If you require more help investing in stocks on eToro, watch the helpful video below:
Step 6: Keep an eye on your investment in KZIA
Now that you own some shares in KZIA, you'll want to stay up-to-date on your new shares.
Put KZIA on a watchlist to see the latest developments about your KZIA stock.
KZIA Feed
How to Buy Stock in Kazia Therapeutics
To summarize, here are the 6 steps to buy Kazia Therapeutics stock:
- Choose where to buy Kazia Therapeutics stock
- Open a brokerage account
- Deposit money your brokerage account
- Research Kazia Therapeutics stock
- Make your KZIA trade
- Keep an eye on your investment in KZIA
If you are looking for a brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you want to get the latest news on your new investment in Kazia Therapeutics, click the button below.
More Stock Buying Guides You Might Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.